References
- Traboulsi EI. Hope and major strides for genetic diseases of the eye. J Genet. 2009;88(4):395–397. doi:10.1007/s12041-009-0060-8
- Chizzolini M, Galan A, Milan E, et al. Good epidemiologic practice in retinitis pigmentosa: from phenotyping to biobanking. Curr Genomics. 2011;12(4):260–266.
- Na KH, Kim HJ, Kim KH, et al. Prevalence, age at diagnosis, mortality, and cause of death in retinitis pigmentosa in Korea-a nationwide population-based study. Am J Ophthalmol. 2017;176(4):157–165.
- Bertelsen M, Jensen H, Bregnhoj JF, Rosenberg T. Prevalence of generalized retinal dystrophy in Denmark. Ophthalmic Epidemiol. 2014;21(4):217–223.
- Bakkar MM, Alzghoul EA, Haddad MF. Clinical characteristics and causes of visual impairment in a low vision clinic in northern Jordan. Clin Ophthalmol. 2018;12:631–637.
- Muñoz-Cuellar JC, RM. Clinical characterization and frequency of observation of hereditary retinal diseases: multicentric study in Panama in 2012-2013. J Pharm Pharmacol. 2016;4:618–630.
- Bocquet B, Lacroux A, Surget MO, et al. Relative frequencies of inherited retinal dystrophies and optic neuropathies in Southern France: assessment of 21-year data management. Ophthalmic Epidemiol. 2013;20(1):13–25.
- Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006;1:40.
- Verbakel SK, van Huet RAC, Boon CJF, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018;66:157–186.
- Costa KA, Salles MV, Whitebirch C, Chiang J, Sallum JMF. Gene panel sequencing in Brazilian patients with retinitis pigmentosa. Int J Retina Vitreous. 2017;3(1):33. doi:10.1186/s40942-017-0087-6
- Gill JS, Georgiou M, Kalitzeos A, Moore AT, Michaelides M. Progressive cone and cone-rod dystrophies: clinical features, molecular genetics and prospects for therapy. Br J Ophthalmol. 2019.
- Clinical Trials Database. U.S National Library, Bethesda. 2000. Available from: https://clinicaltrials.gov. Accessed april 28, 2020.
- Holladay JT. Visual acuity measurements. J Cataract Refract Surg. 2004;30(2):287–290.
- Motta FL, Martin RP, Filippelli-Silva R, Salles MV, Sallum JMF. Relative frequency of inherited retinal dystrophies in Brazil. Sci Rep. 2018;8(1):15939.
- Puech B, Kostrubiec B, Hache JC, Francois P. Epidemiology and prevalence of hereditary retinal dystrophies in the Northern France. J Fr Ophtalmol. 1991;14(3):153–164.
- Gamundi MJ, Hernan I, Muntanyola M, et al. High prevalence of mutations in peripherin/RDS in autosomal dominant macular dystrophies in a Spanish population. Mol Vis. 2007;13:1031–1037.
- Tishkoff SA, Kidd KK. Implications of biogeography of human populations for ‘race’ and medicine. Nat Genet. 2004;36(11 Suppl):S21–7.
- Nirmalan PK, Krishnaiah S, Nutheti R, Shamanna BR, Rao GN, Thomas R. Consanguinity and eye diseases with a potential genetic etiology. Data from a prevalence study in Andhra Pradesh, India. Ophthalmic Epidemiol. 2006;13(1):7–13.
- Berson EL, Rosner B, Simonoff E. Risk factors for genetic typing and detection in retinitis pigmentosa. Am J Ophthalmol. 1980;89(6):763–775.
- Ayuso C, Garcia-Sandoval B, Najera C, Valverde D, Carballo M, Antinolo G. Retinitis pigmentosa in Spain. The Spanish multicentric and multidisciplinary group for research into retinitis pigmentosa. Clin Genet. 1995;48(3):120–122.
- Najera C, Millan JM, Beneyto M, Prieto F. Epidemiology of retinitis pigmentosa in the Valencian community (Spain). Genet Epidemiol. 1995;12(1):37–46.
- Boughman JA, Fishman GA. A genetic analysis of retinitis pigmentosa. Br J Ophthalmol. 1983;67(7):449–454.
- Testa F, Rossi S, Colucci R, et al. Macular abnormalities in Italian patients with retinitis pigmentosa. Br J Ophthalmol. 2014;98(7):946–950.
- Berson EL. Light deprivation and retinitis pigmentosa. Vision Res. 1980;20(12):1179–1184.
- Fujiwara K, Ikeda Y, Murakami Y, et al. Risk factors for posterior subcapsular cataract in retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2017;58(5):2534–2537.
- Jackson H, Garway-Heath D, Rosen P, Bird AC, Tuft SJ. Outcome of cataract surgery in patients with retinitis pigmentosa. Br J Ophthalmol. 2001;85(8):936–938.
- Hartong DT, Berson EL, Dryja TP. Retinitis pigmentosa. Lancet. 2006;368(9549):1795–1809.
- Liew G, Moore AT, Bradley PD, Webster AR, Michaelides M. Factors associated with visual acuity in patients with cystoid macular oedema and Retinitis Pigmentosa. Ophthalmic Epidemiol. 2018;25(3):183–186.
- Hagiwara A, Yamamoto S, Ogata K, et al. Macular abnormalities in patients with retinitis pigmentosa: prevalence on OCT examination and outcomes of vitreoretinal surgery. Acta Ophthalmol. 2011;89(2):e122–5.
- Hajali M, Fishman GA, Anderson RJ. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol. 2008;92(8):1065–1068.
- Battu R, Mallipatna A, Elackatt NJ, Schouten J, Webers CAB. Challenges of managing retinal dystrophies: an experience from south India. Ophthalmic Genet. 2018;39(1):1–3.
- Hirakawa H, Iijima H, Gohdo T, Tsukahara S. Optical coherence tomography of cystoid macular edema associated with retinitis pigmentosa. Am J Ophthalmol. 1999;128(2):185–191.
- EURORDIS: European Organization for Rare Diseases. Eurordis policy fact sheet. 2013. https://www.eurordis.org/sites/default/files/publications/Fact_Sheet_Eurordiscare2.pdf. Accessed November 28, 2019.
- Zeitz C, Robson AG, Audo I. Congenital stationary night blindness: an analysis and update of genotype-phenotype correlations and pathogenic mechanisms. Prog Retin Eye Res. 2015;45:58–110.